Agency Forms Undergoing Paperwork Reduction Act Review, 7904-7905 [E9-3651]
Download as PDF
7904
David C. Shonka
Acting General Counsel
[FR Doc. E9–3645 Filed 2–19–09: 8:45 am]
BILLING CODE 6750–01–C
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–08–0494]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
VerDate Nov<24>2008
17:55 Feb 19, 2009
Jkt 217001
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
E:\FR\FM\20FEN1.SGM
20FEN1
EN20FE09.005
Federal Register / Vol. 74, No. 33 / Friday, February 20, 2009 / Notices
7905
Federal Register / Vol. 74, No. 33 / Friday, February 20, 2009 / Notices
Proposed Project
Exposure to Aerosolized Brevetoxins
during Red Tide Events (OMB No.
0920–0494)—Reinstatement with
change—National Center for
Environmental Health (NCEH), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
Karenia brevis (formerly
Gymnodinium breve) is the marine
dinoflagellate responsible for extensive
blooms (called Florida red tides) that
form in the Gulf of Mexico. K. brevis
produces potent toxins, called
brevetoxins, which have been
responsible for killing millions of fish
and other marine organisms. The
biochemical activity of brevetoxins is
not completely understood and there is
still little information regarding human
health effects from environmental
exposures, such as inhaling brevetoxin
that has been aerosolized and swept
onto the coast by offshore winds. The
National Center for Environmental
Health (NCEH), Centers for Disease
Control and Prevention (CDC) has
recruited people who work along the
coast of Florida and who are
periodically occupationally exposed to
aerosolized red tide toxins.
NCEH administered a baseline
respiratory health survey and conducted
pre- and post-shift pulmonary function
tests (PFTs) during a time when there is
no red tide reported near the area. When
a red tide developed, NCEH
administered a symptom survey and
conducted PFTs. NCEH compared
symptoms reported before the shift with
symptoms reported after the shift. NCEH
also examined changes in PFT test
results (post-shift values compared to
pre-shift values). NCEH did these
comparisons during a time when there
was no red tide and during a time when
there was a red tide and then examined
the data to see if red tide exposure had
an effect on symptom reports or PFT
results.
NCEH requests a reinstatement with
change of data collection procedures for
the previously approved project for an
additional three years. The respondents
for this reinstatement with change are a
recruited group of approximately 25
lifeguards (aged ≥18) who work along
the coast of Florida and who
periodically are occupationally exposed
to aerosolized red tide toxins. The
lifeguards and employees of the
Department of Environmental
Protection, (Sarasota County), Florida
were recruited via a posted notice
requesting volunteers. NCEH plans to
re-contact study participants previously
enrolled and add additional lifeguards
hired previously to work at the relevant
beaches.
Unfortunately, the exposures
experienced by the study cohort have
been minimal, and NCEH plans to
conduct another study (using the same
symptom surveys and PFTs) during a
more severe red tide event. First, NCEH
wants to quantify the levels of cytokines
in nasal exudates to assess whether they
can be used to verify exposure and to
demonstrate a biological effect (i.e.,
allergic response) following inhalation
of aerosolized brevetoxins. NCEH will
collect nasal exudates at the same time
the PFTs are done. We propose to add
a component to this study to assess
whether loratidine, an antihistamine
available in over-the-counter products,
such as Claritin, can relieve the upper
respiratory symptoms induced by
inhaling aerosolized brevetoxins during
Florida red tides.
There is no cost to respondents other
than their time. The total estimated
annual burden hours are 16.
ESTIMATED ANNUALIZED BURDEN HOURS
Instrument type
New study participants .............................
Lifeguards (previous participants and
new).
Pulmonary Health Questionnaire .............
Pre- and Post-Shift Red Tide Questionnaire.
Dated: February 12, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–3651 Filed 2–19–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–09–0762]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
VerDate Nov<24>2008
17:55 Feb 19, 2009
Jkt 217001
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 or send
comments to Maryam Daneshvar, Acting
CDC Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
PO 00000
Frm 00056
Fmt 4703
No. of responses
per respondent
No. of
respondents
Type of respondents
Sfmt 4703
Average burden
per response
(in hours)
1
6
20/60
5/60
10
25
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Formative Research to Inform an HIV
Testing Social Marketing Campaign for
African American Men Who Have Sex
With Men (MSM), (OMB No. 0920–
0762)—Revision—National Center for
HIV/AIDS, Viral Hepatitis, Sexually
Transmitted Diseases, and Tuberculosis
Elimination Programs (NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The purpose of the proposed study is
to conduct formative research to inform
the development of the HIV Testing
Social Marketing Campaign for African
American MSM, a CDC-sponsored social
marketing campaign aimed at increasing
HIV testing rates among young, African
E:\FR\FM\20FEN1.SGM
20FEN1
Agencies
[Federal Register Volume 74, Number 33 (Friday, February 20, 2009)]
[Notices]
[Pages 7904-7905]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-3651]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-08-0494]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
[[Page 7905]]
Proposed Project
Exposure to Aerosolized Brevetoxins during Red Tide Events (OMB No.
0920-0494)--Reinstatement with change--National Center for
Environmental Health (NCEH), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
Karenia brevis (formerly Gymnodinium breve) is the marine
dinoflagellate responsible for extensive blooms (called Florida red
tides) that form in the Gulf of Mexico. K. brevis produces potent
toxins, called brevetoxins, which have been responsible for killing
millions of fish and other marine organisms. The biochemical activity
of brevetoxins is not completely understood and there is still little
information regarding human health effects from environmental
exposures, such as inhaling brevetoxin that has been aerosolized and
swept onto the coast by offshore winds. The National Center for
Environmental Health (NCEH), Centers for Disease Control and Prevention
(CDC) has recruited people who work along the coast of Florida and who
are periodically occupationally exposed to aerosolized red tide toxins.
NCEH administered a baseline respiratory health survey and
conducted pre- and post-shift pulmonary function tests (PFTs) during a
time when there is no red tide reported near the area. When a red tide
developed, NCEH administered a symptom survey and conducted PFTs. NCEH
compared symptoms reported before the shift with symptoms reported
after the shift. NCEH also examined changes in PFT test results (post-
shift values compared to pre-shift values). NCEH did these comparisons
during a time when there was no red tide and during a time when there
was a red tide and then examined the data to see if red tide exposure
had an effect on symptom reports or PFT results.
NCEH requests a reinstatement with change of data collection
procedures for the previously approved project for an additional three
years. The respondents for this reinstatement with change are a
recruited group of approximately 25 lifeguards (aged >=18) who work
along the coast of Florida and who periodically are occupationally
exposed to aerosolized red tide toxins. The lifeguards and employees of
the Department of Environmental Protection, (Sarasota County), Florida
were recruited via a posted notice requesting volunteers. NCEH plans to
re-contact study participants previously enrolled and add additional
lifeguards hired previously to work at the relevant beaches.
Unfortunately, the exposures experienced by the study cohort have
been minimal, and NCEH plans to conduct another study (using the same
symptom surveys and PFTs) during a more severe red tide event. First,
NCEH wants to quantify the levels of cytokines in nasal exudates to
assess whether they can be used to verify exposure and to demonstrate a
biological effect (i.e., allergic response) following inhalation of
aerosolized brevetoxins. NCEH will collect nasal exudates at the same
time the PFTs are done. We propose to add a component to this study to
assess whether loratidine, an antihistamine available in over-the-
counter products, such as Claritin, can relieve the upper respiratory
symptoms induced by inhaling aerosolized brevetoxins during Florida red
tides.
There is no cost to respondents other than their time. The total
estimated annual burden hours are 16.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average burden
Type of respondents Instrument type No. of No. of responses per response (in
respondents per respondent hours)
----------------------------------------------------------------------------------------------------------------
New study participants............. Pulmonary Health 10 1 20/60
Questionnaire.
Lifeguards (previous participants Pre- and Post-Shift 25 6 5/60
and new). Red Tide
Questionnaire.
----------------------------------------------------------------------------------------------------------------
Dated: February 12, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E9-3651 Filed 2-19-09; 8:45 am]
BILLING CODE 4163-18-P